Oxygerolan (Oxycodone Hydrochloride)

Oxygerolan is an opioid analgesic that acts on the central nervous system to manage pain across several clinical contexts.

• Acute postoperative pain: Provides effective relief when non‑opioid analgesics are inadequate.
• Cancer‑related pain: Helps control persistent pain associated with malignant disease.
• Chronic non‑cancer pain: Used in selected cases where long‑term opioid therapy is justified.
• Severe traumatic injury pain: Alleviates intense pain following major trauma.

• Oxycodone hydrochloride binds selectively to μ‑opioid receptors in the central nervous system, activating inhibitory G‑protein pathways that reduce neuronal excitability and diminish the perception of pain. This receptor activation also modulates neurotransmitter release, contributing to its analgesic effect.

Oxygerolan may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects

• Nausea and vomiting: Mild to moderate gastrointestinal upset.
• Constipation: Reduced bowel motility leading to hard stools.
• Drowsiness: Sedation that may affect alertness.
• Dizziness: Light‑headed sensation, especially on standing.
• Dry mouth: Reduced salivary flow causing oral discomfort.
• Pruritus: Itching without rash.

Serious or Rare Side Effects

• Respiratory depression: Reduced breathing rate, potentially life‑threatening.
• Severe hypotension: Marked drop in blood pressure.
• Opioid use disorder: Risk of dependence with prolonged use.
• Adrenal insufficiency: Rare endocrine dysfunction.
• Allergic reactions: Anaphylaxis or severe skin rash.
• QT prolongation: Cardiac rhythm disturbance in susceptible individuals.

When prescribing Oxygerolan, clinicians should consider several safety measures to minimize risk.

• Assess pain severity: Confirm that opioid therapy is appropriate for the patient’s level of pain.
• Evaluate history: Screen for prior opioid use, substance abuse, or respiratory disorders.
• Monitor for sedation: Observe patients for excessive drowsiness or impaired cognition.
• Adjust for renal/hepatic impairment: Dose may need modification in organ dysfunction.
• Educate on constipation: Recommend laxatives or stool softeners as needed.
• Store at ambient temperature: Keep below 25°C in the original packaging, protected from moisture.

Oxygerolan can interact with several medication classes, altering its efficacy or safety profile.

Major Interactions (Avoid)

• CNS depressants: Concurrent use with benzodiazepines or barbiturates can cause profound respiratory depression.
• MAO inhibitors: May precipitate severe hypertension or serotonin syndrome.
• CYP3A4 inhibitors: Strong inhibitors (e.g., ketoconazole) can increase oxycodone plasma levels.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors: Medications like fluoxetine may modestly raise oxycodone concentrations.
• Anticholinergics: May exacerbate constipation.
• Diuretics: Can enhance orthostatic hypotension risk.